Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Addus HomeCare
DA
DanielGC
Community Contributor
Quality at a Premium. A time to watch, not to buy?
Key Takeaways Consistent revenue growth, strong profitability, and a pristine balance sheet position Addus for sustained disciplined acquisitive growth and improved operational efficiency. The company's business model is resilient and defensive against cyclical downturns, making it a safe haven in times of economic uncertainty.
View narrative
US$154.56
FV
27.6% undervalued
intrinsic discount
14.72%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
2
users have commented on this narrative
36
users have followed this narrative
about 1 month ago
author updated this narrative
Grab Holdings
BL
BlackGoat
Community Contributor
GRAB: The Super-App at the Heart of Southeast Asia’s Digital Boom
Why I Began Following This Company… My interest in Grab begins with the region it calls home. Southeast Asia is entering a transformative decade: young, fast-growing, and increasingly digital.
View narrative
US$8.2
FV
22.1% undervalued
intrinsic discount
21.73%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
3
users have commented on this narrative
53
users have followed this narrative
Updated
narrative
Verve Group
ME
MEB
Community Contributor
Verve Group to Surge with 51.61% Revenue Growth
Verve Group faces near-term skepticism following its FY25 Q2 report, which included a downward revision to full-year revenue guidance. But beneath the short-term noise lies a company undergoing a strategic inflection — one that positions it to capture outsized value in the post-cookie, privacy-first advertising economy.
View narrative
€6
FV
60.0% undervalued
intrinsic discount
58.08%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
23
users have followed this narrative
18 days ago
author updated this narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
thyssenkrupp
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Rising Cost Burdens Will Depress Margins Despite Decarb Opportunities
Key Takeaways Decarbonization pressures, alternative materials, and persistent overcapacity threaten core steel demand, margins, and long-term viability against intensifying global competition. Poor restructuring execution and heavy legacy obligations restrict innovation, financial flexibility, and capacity to adapt or invest for future growth.
View narrative
€6.3
FV
84.6% overvalued
intrinsic discount
0.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
12 days ago
author updated this narrative
Avadel Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Rising Awareness Of Sleep Disorders Will Drive Future Demand
Key Takeaways LUMRYZ's adoption and differentiated dosing profile are fueling strong growth and establishing a sustainable competitive edge amid rising sleep disorder awareness and demand for innovation. Expansion into new indications and strengthened intellectual property position enhance long-term revenue potential, diversification, and protection against competitive threats.
View narrative
US$20.2
FV
19.8% undervalued
intrinsic discount
26.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
12 days ago
author updated this narrative
Alnylam Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 28 Analysts
RNAi Therapies Will Ensure Worldwide Market Expansion
Key Takeaways Growing market adoption and global expansion of core RNAi therapies, alongside efficient payer access, are driving sustained revenue growth and operational leverage. Advancing pipeline assets and leadership in rare disease innovation position the company to benefit from ongoing healthcare sector trends and precision medicine expansion.
View narrative
US$421.2
FV
7.7% overvalued
intrinsic discount
41.58%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
12 days ago
author updated this narrative
Idorsia
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Global Expansion And FDA Review Will Moderate Overvaluation
Key Takeaways Market optimism for rapid revenue growth may be premature, with unvalidated access, uncertain drug uptake, and regulatory outcomes adding risk to earnings expectations. Longer-term valuation appears inflated by pipeline commercialization hopes, while rising costs and increasing pricing scrutiny threaten future margins and profitability.
View narrative
CHF 2
FV
101.5% overvalued
intrinsic discount
17.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
4
users have followed this narrative
12 days ago
author updated this narrative
B2Gold
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Digital Currencies And Regulatory Burdens Will Erode Gold Allure
Key Takeaways The shift towards digital assets, tighter green regulations, and low-quality reserves threaten B2Gold's revenue stability, cost structure, and future production growth prospects. High dependence on risk-prone regions and increased regulatory scrutiny could lead to volatile earnings and hamper access to institutional capital.
View narrative
CA$5.39
FV
15.3% overvalued
intrinsic discount
15.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
12 days ago
author updated this narrative
United Internet
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Saturated European Markets And Heavy CapEx Will Undermine Future Prospects
Key Takeaways Market saturation, rising competition, and new digital ecosystems will constrain growth and erode both market share and pricing power in core segments. High capital expenditures and escalating regulatory costs will suppress free cash flow, net margins, and reduce strategic flexibility over time.
View narrative
€14.46
FV
91.2% overvalued
intrinsic discount
1.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
12 days ago
author updated this narrative
Enghouse Systems
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Acquisitions Of Aculab And Margento Will Expand Services In High-Demand Sectors
Key Takeaways Strategic acquisitions and a shift to a dual SaaS/on-premise model are expected to boost revenue, net margins, and earnings stability. A strong financial position with no debt enables dividend increases, share buybacks, and improved EPS and return on equity.
View narrative
CA$23.67
FV
9.7% undervalued
intrinsic discount
5.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
42
users have followed this narrative
12 days ago
author updated this narrative
Stellantis
AN
AnalystConsensusTarget
Consensus Narrative from 26 Analysts
Electrification And Global Market Expansion Will Unlock Value
Key Takeaways Electrification initiatives and new model launches position Stellantis to gain market share and fuel revenue growth as electric vehicle adoption accelerates. Operating margin improvements, strategic product cuts, and investments in software and refreshed brands support future profitability and recurring revenue resilience.
View narrative
€9.38
FV
9.9% undervalued
intrinsic discount
6.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
118
users have followed this narrative
12 days ago
author updated this narrative
Centuria Capital Group
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Australia And New Zealand Trends And AI Will Reshape Markets
Key Takeaways Diversification into healthcare, alternative real estate, and digital infrastructure is reducing earnings volatility and creating multiple recurring revenue streams. Easing borrowing conditions and a shift toward real asset investments are boosting investor inflows, supporting growth in funds under management and operating earnings.
View narrative
AU$2.32
FV
0.05% undervalued
intrinsic discount
-7.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
12 days ago
author updated this narrative